Thyrocare Technologies Limited (THYROCARE)

960.25

INR
-31.30(-3.16%)
As of December 13, 2024 9:35:00 AM

Thyrocare Technologies Limited Share Price Information

24 hour Low and High

Low: 961.1
High: 1042.85

All time High

1369.00

Price Change 1h

+₹-31.30 +-3.16%

Price Change 1d

+₹-31.30 +-3.16%

Price Change 1w

+₹-16.30 +-1.67%

Thyrocare Technologies Limited Market Information

Exchange

NSE

Market Cap

₹5029.43 Cr

About Thyrocare Technologies Limited Share

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Sector

Healthcare

Diagnostics & Research

Employees

about

1693

CEO

Mr. Rahul Franklin Guha

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Thyrocare Technologies share surge 19% to hit fresh all-time high; what's driving the rally? | Stock Market News
  • Thyrocare Tech stock skyrockets 17% post Q1FY25 results; details here
  • Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-Street
  • Coforge, Thyrocare Technologies, Dishman Carbogen: How to trade these 3 buzzing stocks
  • Thyrocare shares jump to the highest in a year after multi-quarter high revenue, margin

FAQs

Thyrocare Technologies Limited (THYROCARE)

960.25

INR
-31.30(-3.16%)
As of December 13, 2024 9:35:00 AM

Thyrocare Technologies Limited Share Price Information

24 hour Low and High

Low: 961.1
High: 1042.85

All time High

1369.00

Price Change 1h

+₹-31.30 +-3.16%

Price Change 1d

+₹-31.30 +-3.16%

Price Change 1w

+₹-16.30 +-1.67%

Thyrocare Technologies Limited Market Information

Exchange

NSE

Market Cap

₹5029.43 Cr

About Thyrocare Technologies Limited Share

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Sector

Healthcare

Diagnostics & Research

Employees

about

1693

CEO

Mr. Rahul Franklin Guha

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Thyrocare Technologies share surge 19% to hit fresh all-time high; what's driving the rally? | Stock Market News
  • Thyrocare Tech stock skyrockets 17% post Q1FY25 results; details here
  • Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-Street
  • Coforge, Thyrocare Technologies, Dishman Carbogen: How to trade these 3 buzzing stocks
  • Thyrocare shares jump to the highest in a year after multi-quarter high revenue, margin

FAQs